Evonik looks to boost productivity of cell-culture-based biopharmaceuticals
Evonik has launched a new peptide, the latest addition to its cQrex portfolio.
Archives for June 7, 2022
Johnson & Johnson ending COVID-19 vaccine contract with Emergent
Johnson & Johnson (J&J) has officially informed Emergent BioSolutions Inc of its decision to terminate its agreement with the contract manufacturer in relation to the pharma group’s COVID-19 vaccine.
Bavarian Nordic enters smallpox vaccine contract with Canadian government
The Public Health Agency of Canada (PHAC) will purchase Bavarian Nordic’s smallpox vaccine Imvamune in a five-year contract worth around $56m.
Moderna takes mRNA influenza candidate into Phase 3 trials
Moderna has dosed the first participants in a Phase 3 study of the company’s seasonal influenza vaccine candidate, mRNA-1010.